Skip to main content
OpenTrials
Completed

NCT Number: NCT01212601

Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice

This is a Multicenter, observational, non-interventional registry designed to collect clinical data in Chinese patients who have received CUBICIN treatment under condition of actual usage in clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

S. Aureus Bloodstream Infection

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Beijing, Beijing Municipality, China

Loading trial locations.

About this study

MC MD

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient has received CUBICIN treatment, decided by treating physician
  • A patient who is considered as ethnic Chinese
  • Provision of subject informed consent

Exclusion criteria

  • A patient record will not be eligible for the registry database if the patient received CUBICIN as part of a controlled clinical study for the current infection episode.

Treatment and study plan

Primary outcomes

  1. AEs of CUBICIN therapy

    Time frame: 2 weeks

  2. clinical response of CUBICIN therapy at each available time point

    Time frame: 2 weeks

Secondary outcomes

  1. CPK level monitoring and results

    Time frame: 2 weeks

  2. treatment duration

    Time frame: 2 weeks

  3. Time to clinical response

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Multicenter, Observational, Non-interventional Registry Designed to Collect Clinical Data in Chinese Patients Who Have Received CUBICIN® Treatment Under Condition of Actual Usage in Clinical Practice

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Sep 30, 2010
Registry last updated
Nov 27, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.